Aura Biosciences, Inc. (AURA) stock

AURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30

$7.11−0.50 (-6.57%)

Close on Nov 12, 2026Market cap $737.34MP/E –Yield –

Aura Biosciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Aura Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?